ENANTA PHARMACEUTICALS, INC
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $280.7M
Liabilities Breakdown FY2025
Total Liabilities: $216.0M
Asset Breakdown
Total Assets: $280.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $32.3M | 11.5% |
| Accounts Receivable | $6.9M | 2.5% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $35.4M | 12.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $206.2M | 73.4% |
Liabilities Breakdown
Total Liabilities: $216.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.9M | 0.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $214.1M | 99.1% |